3 months ago
VKTX
AnalystsAnnabel SamimyAnnabel Samimy's Stock Forecasts
AnalystsAnnabel Samimy
Analyst Ranking
Top 6%
#257 out of 4595 analysts
Average Return
+42.6%
Win Rate
49%22 out of 45
Risk vs Reward
Poor
Good
Annabel Samimy's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Viking Therapeutics IncVKTX | +439.77% | $15.44 | $83.34 | 2023-03-28 - 2024-03-27 | Strong Buy |
Viking Therapeutics IncVKTX | +428.83% | $11.83 | $62.56 | 2023-03-17 - 2024-03-15 | Strong Buy |
Viking Therapeutics IncVKTX | +337.83% | $14.22 | $62.26 | 2023-08-08 - 2024-05-31 | Strong Buy |
Prometheus Biosciences IncRXDX | +276.85% | $51.35 | $193.51 | 2022-11-01 - 2023-04-17 | Strong Buy |
Viking Therapeutics IncVKTX | +216.53% | $24.65 | $78.01 | 2023-05-16 - 2024-05-15 | Strong Buy |
Annabel Samimy Analyst Color
Get additional color on Annabel Samimy's coverage of popular stocks
3 months ago
JAZZ
3 months ago
EOLS
4 months ago
VKTX
9 months ago
APLS
a year ago
VKTX
a year ago
RXDX
a year ago
RETA
a year ago
VKTX
Annabel Samimy's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Calliditas Therapeutics AbCALT | 2 | Hold | $40.00 | +0.03% | Downgrades | 5 days ago |
Phathom Pharmaceuticals IncPHAT | 1 | Strong Buy | $24.00 | +154.78% | Initiates Coverage On | a month ago |
Regenxbio IncRGNX | 2 | Strong Buy | $40.00 | +178.75% | Maintains | 2 months ago |
Viking Therapeutics IncVKTX | 6 | Strong Buy | $80.00 | +28.49% | Reiterates | 3 months ago |
Jazz Pharmaceuticals PLCJAZZ | 3 | Strong Buy | $230.00 | +118.53% | Maintains | 3 months ago |
Evolus IncEOLS | 1 | Strong Buy | $25.00 | +93.35% | Reiterates | 3 months ago |
Inventiva SaIVA | 2 | Strong Buy | $25.00 | +581.20% | Maintains | 4 months ago |
Oculis Holding AgOCS | 1 | Strong Buy | $35.00 | +197.62% | Initiates Coverage On | 8 months ago |
Apellis Pharmaceuticals IncAPLS | 3 | Strong Buy | $65.00 | +65.61% | Maintains | 9 months ago |
Reata Pharmaceuticals IncRETA | 2 | Hold | $172.50 | +0.08% | Downgrades | 10 months ago |
Cara Therapeutics IncCARA | 2 | Strong Buy | $28.00 | +4,214.33% | Reiterates | a year ago |
Fibrogen IncFGEN | 2 | Hold | $11.00 | +816.67% | Downgrades | a year ago |
Prometheus Biosciences IncRXDX | 2 | Hold | $200.00 | N/A | Downgrades | a year ago |
Mineralys Therapeutics IncMLYS | 1 | Strong Buy | $45.00 | N/A | Initiates Coverage On | a year ago |
Horizon Therapeutics Public Ltd CoHZNP | 4 | Hold | $116.50 | N/A | Downgrades | a year ago |
Clearside Biomedical IncCLSD | 1 | Strong Buy | $8.00 | N/A | Upgrades | 2 years ago |
Evofem Biosciences IncEVFM | 2 | Hold | $0.50 | N/A | Downgrades | 2 years ago |
Iveric Bio IncISEE | 2 | Strong Buy | $35.00 | N/A | Maintains | 2 years ago |
Aerie Pharmaceuticals IncAERI | 2 | Hold | $15.25 | N/A | Downgrades | 2 years ago |
Elicio Therapeutics IncELTX | 3 | Hold | $15.00 | N/A | Downgrades | 2 years ago |
Rani Therapeutics Holdings IncRANI | 1 | Strong Buy | $24.00 | N/A | Initiates Coverage On | 3 years ago |
Radius Health IncRDUS1 | 1 | Hold | $20.00 | N/A | Initiates Coverage On | 4 years ago |
Therapeuticsmd IncTXMD | 3 | Strong Buy | $750.00 | N/A | Maintains | 4 years ago |
Supernus Pharmaceuticals IncSUPN | 4 | Hold | $24.00 | N/A | Maintains | 4 years ago |
Revance Therapeutics IncRVNC | 1 | Strong Buy | $31.00 | N/A | Maintains | 4 years ago |
Durect CorpDRRX | 4 | Hold | $21.00 | N/A | Maintains | 5 years ago |
Zogenix IncZGNX | 2 | Strong Buy | $61.00 | N/A | Maintains | 5 years ago |
Endo International PLCENDPQ | 2 | Hold | $17.00 | N/A | Maintains | 6 years ago |
Innocoll Holdings PLCINNL | 1 | Hold | N/A | N/A | Downgrades | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.